Global Prostate Cancer Medicine Sales Market Report 2017


Report ID : RNR-199595 Category : Pharma Healthcare Published Date : Nov 2017
Publisher : QYResearch Pages : 104 Format : PDF
In this report, the global Prostate Cancer Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Prostate Cancer Medicine for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Prostate Cancer Medicine market competition by top manufacturers/players, with Prostate Cancer Medicine sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
AstraZeneca plc
Active Biotech
Bristol Myers-Squibb
Teva Pharmaceuticals Industries Ltd.
Johnson & Johnson
Pfizer Inc.
Bayer AG
Abbott Laboratories
Astellas Pharma Inc.
Roche Holding AG
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Hormonal Therapy Drugs
Chemotherapy Drugs
Immunotherapy Drugs
Target Therapy Drugs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Prostate Cancer Medicine for each application, including
Hospital
Pharmacy
Others

If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents

Global Prostate Cancer Medicine Sales Market Report 2017
1 Prostate Cancer Medicine Market Overview
1.1 Product Overview and Scope of Prostate Cancer Medicine
1.2 Classification of Prostate Cancer Medicine by Product Category
1.2.1 Global Prostate Cancer Medicine Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Prostate Cancer Medicine Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Hormonal Therapy Drugs
1.2.4 Chemotherapy Drugs
1.2.5 Immunotherapy Drugs
1.2.6 Target Therapy Drugs
1.3 Global Prostate Cancer Medicine Market by Application/End Users
1.3.1 Global Prostate Cancer Medicine Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Global Prostate Cancer Medicine Market by Region
1.4.1 Global Prostate Cancer Medicine Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Prostate Cancer Medicine Status and Prospect (2012-2022)
1.4.3 China Prostate Cancer Medicine Status and Prospect (2012-2022)
1.4.4 Europe Prostate Cancer Medicine Status and Prospect (2012-2022)
1.4.5 Japan Prostate Cancer Medicine Status and Prospect (2012-2022)
1.4.6 Southeast Asia Prostate Cancer Medicine Status and Prospect (2012-2022)
1.4.7 India Prostate Cancer Medicine Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Prostate Cancer Medicine (2012-2022)
1.5.1 Global Prostate Cancer Medicine Sales and Growth Rate (2012-2022)
1.5.2 Global Prostate Cancer Medicine Revenue and Growth Rate (2012-2022)

2 Global Prostate Cancer Medicine Competition by Players/Suppliers, Type and Application
2.1 Global Prostate Cancer Medicine Market Competition by Players/Suppliers
2.1.1 Global Prostate Cancer Medicine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Prostate Cancer Medicine Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Prostate Cancer Medicine (Volume and Value) by Type
2.2.1 Global Prostate Cancer Medicine Sales and Market Share by Type (2012-2017)
2.2.2 Global Prostate Cancer Medicine Revenue and Market Share by Type (2012-2017)
2.3 Global Prostate Cancer Medicine (Volume and Value) by Region
2.3.1 Global Prostate Cancer Medicine Sales and Market Share by Region (2012-2017)
2.3.2 Global Prostate Cancer Medicine Revenue and Market Share by Region (2012-2017)
2.4 Global Prostate Cancer Medicine (Volume) by Application

3 United States Prostate Cancer Medicine (Volume, Value and Sales Price)
3.1 United States Prostate Cancer Medicine Sales and Value (2012-2017)
3.1.1 United States Prostate Cancer Medicine Sales and Growth Rate (2012-2017)
3.1.2 United States Prostate Cancer Medicine Revenue and Growth Rate (2012-2017)
3.1.3 United States Prostate Cancer Medicine Sales Price Trend (2012-2017)
3.2 United States Prostate Cancer Medicine Sales Volume and Market Share by Players
3.3 United States Prostate Cancer Medicine Sales Volume and Market Share by Type
3.4 United States Prostate Cancer Medicine Sales Volume and Market Share by Application

4 China Prostate Cancer Medicine (Volume, Value and Sales Price)
4.1 China Prostate Cancer Medicine Sales and Value (2012-2017)
4.1.1 China Prostate Cancer Medicine Sales and Growth Rate (2012-2017)
4.1.2 China Prostate Cancer Medicine Revenue and Growth Rate (2012-2017)
4.1.3 China Prostate Cancer Medicine Sales Price Trend (2012-2017)
4.2 China Prostate Cancer Medicine Sales Volume and Market Share by Players
4.3 China Prostate Cancer Medicine Sales Volume and Market Share by Type
4.4 China Prostate Cancer Medicine Sales Volume and Market Share by Application

5 Europe Prostate Cancer Medicine (Volume, Value and Sales Price)
5.1 Europe Prostate Cancer Medicine Sales and Value (2012-2017)
5.1.1 Europe Prostate Cancer Medicine Sales and Growth Rate (2012-2017)
5.1.2 Europe Prostate Cancer Medicine Revenue and Growth Rate (2012-2017)
5.1.3 Europe Prostate Cancer Medicine Sales Price Trend (2012-2017)
5.2 Europe Prostate Cancer Medicine Sales Volume and Market Share by Players
5.3 Europe Prostate Cancer Medicine Sales Volume and Market Share by Type
5.4 Europe Prostate Cancer Medicine Sales Volume and Market Share by Application

6 Japan Prostate Cancer Medicine (Volume, Value and Sales Price)
6.1 Japan Prostate Cancer Medicine Sales and Value (2012-2017)
6.1.1 Japan Prostate Cancer Medicine Sales and Growth Rate (2012-2017)
6.1.2 Japan Prostate Cancer Medicine Revenue and Growth Rate (2012-2017)
6.1.3 Japan Prostate Cancer Medicine Sales Price Trend (2012-2017)
6.2 Japan Prostate Cancer Medicine Sales Volume and Market Share by Players
6.3 Japan Prostate Cancer Medicine Sales Volume and Market Share by Type
6.4 Japan Prostate Cancer Medicine Sales Volume and Market Share by Application

7 Southeast Asia Prostate Cancer Medicine (Volume, Value and Sales Price)
7.1 Southeast Asia Prostate Cancer Medicine Sales and Value (2012-2017)
7.1.1 Southeast Asia Prostate Cancer Medicine Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Prostate Cancer Medicine Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Prostate Cancer Medicine Sales Price Trend (2012-2017)
7.2 Southeast Asia Prostate Cancer Medicine Sales Volume and Market Share by Players
7.3 Southeast Asia Prostate Cancer Medicine Sales Volume and Market Share by Type
7.4 Southeast Asia Prostate Cancer Medicine Sales Volume and Market Share by Application

8 India Prostate Cancer Medicine (Volume, Value and Sales Price)
8.1 India Prostate Cancer Medicine Sales and Value (2012-2017)
8.1.1 India Prostate Cancer Medicine Sales and Growth Rate (2012-2017)
8.1.2 India Prostate Cancer Medicine Revenue and Growth Rate (2012-2017)
8.1.3 India Prostate Cancer Medicine Sales Price Trend (2012-2017)
8.2 India Prostate Cancer Medicine Sales Volume and Market Share by Players
8.3 India Prostate Cancer Medicine Sales Volume and Market Share by Type
8.4 India Prostate Cancer Medicine Sales Volume and Market Share by Application

9 Global Prostate Cancer Medicine Players/Suppliers Profiles and Sales Data
9.1 AstraZeneca plc
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Prostate Cancer Medicine Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 AstraZeneca plc Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Active Biotech
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Prostate Cancer Medicine Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Active Biotech Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Bristol Myers-Squibb
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Prostate Cancer Medicine Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Teva Pharmaceuticals Industries Ltd.
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Prostate Cancer Medicine Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Johnson & Johnson
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Prostate Cancer Medicine Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Johnson & Johnson Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Pfizer Inc.
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Prostate Cancer Medicine Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Pfizer Inc. Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Bayer AG
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Prostate Cancer Medicine Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Bayer AG Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Abbott Laboratories
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Prostate Cancer Medicine Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Abbott Laboratories Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Astellas Pharma Inc.
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Prostate Cancer Medicine Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Roche Holding AG
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Prostate Cancer Medicine Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Roche Holding AG Prostate Cancer Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview

10 Prostate Cancer Medicine Maufacturing Cost Analysis
10.1 Prostate Cancer Medicine Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Prostate Cancer Medicine
10.3 Manufacturing Process Analysis of Prostate Cancer Medicine

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Prostate Cancer Medicine Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Prostate Cancer Medicine Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Prostate Cancer Medicine Market Forecast (2017-2022)
14.1 Global Prostate Cancer Medicine Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Prostate Cancer Medicine Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Prostate Cancer Medicine Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Prostate Cancer Medicine Price and Trend Forecast (2017-2022)
14.2 Global Prostate Cancer Medicine Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Prostate Cancer Medicine Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Prostate Cancer Medicine Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Prostate Cancer Medicine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Prostate Cancer Medicine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Prostate Cancer Medicine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Prostate Cancer Medicine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Prostate Cancer Medicine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Prostate Cancer Medicine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Prostate Cancer Medicine Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Prostate Cancer Medicine Sales Forecast by Type (2017-2022)
14.3.2 Global Prostate Cancer Medicine Revenue Forecast by Type (2017-2022)
14.3.3 Global Prostate Cancer Medicine Price Forecast by Type (2017-2022)
14.4 Global Prostate Cancer Medicine Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion